Argos Therapeutics, Inc. to Present at the Stifel Nicolaus 2012 Healthcare Conference

DURHAM, N.C., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced today that Jeff Abbey, President and Chief Executive Officer, is scheduled to present at the Stifel Nicolaus 2012 Healthcare Conference at the Four Seasons Hotel in Boston.

Back to news